CREO MEDICAL GROUP PLC
Creo Medical Group plc is an AIM-listed medical device company that develops and commercialises minimally invasive electrosurgical instruments for endoscopy, bronchoscopy, and laparoscopy.
Get an alert when CREO MEDICAL GROUP PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£12M
+42.5% highest in 3 filed years
Net assets
£50M
+17.9% vs 2024
Employees
133
-20.4% lowest in 3 filed years
Profit before tax
-£18M
+39.7% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The Directors have assessed the Group’s ability to continue as a going concern, taking into account its financial position, cash flow forecasts, liquidity and the principal risks and uncertainties facing the business. The Group continues to invest in commercialisation and research and development and is expected to incur operating losses and cash outflows in the near term and that current expenditure levels indicate that additional funding will be required. The Group continues to have a material uncertainty over the Group's ability to continue as a going concern.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £30,800,000 | £4,000,000 | £6,000,000 | +50% | |
| Operating profit | £600,000 | -£28,800,000 | -£17,800,000 | +38.2% | |
| Profit before tax | £600,000 | -£29,000,000 | -£17,500,000 | +39.7% | |
| Net profit | — | — | — | — | |
| Cash | £3,000,000 | £8,700,000 | £12,400,000 | +42.5% | |
| Total assets less current liabilities | £62,400,000 | £61,100,000 | £52,200,000 | -14.6% | |
| Net assets | £59,800,000 | £42,400,000 | £50,000,000 | +17.9% | |
| Equity | £59,800,000 | £42,400,000 | £50,000,000 | +17.9% | |
| Average employees | 287 | 167 | 133 | -20.4% | |
| Wages | £12,800,000 | £7,900,000 | £10,400,000 | +31.6% | |
| Directors' remuneration | £3,042,236 | £1,419,519 | £1,617,368 | +13.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 1.9% | — | — | |
| Return on capital employed | 1.0% | -47.1% | -34.1% | |
| Gearing (liabilities / total assets) | 21.9% | 34.8% | 15.4% | |
| Current ratio | 0.61x | 10.49x | 2.97x | |
| Interest cover | 3.00x | -41.14x | -44.50x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CREO MEDICAL GROUP PLC 2016-11-28 → present
- CREO MEDICAL GROUP LIMITED 2016-09-12 → 2016-11-28
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The Directors have assessed the Group’s ability to continue as a going concern, taking into account its financial position, cash flow forecasts, liquidity and the principal risks and uncertainties facing the business. The Group continues to invest in commercialisation and research and development and is expected to incur operating losses and cash outflows in the near term and that current expenditure levels indicate that additional funding will be required. The Group continues to have a material uncertainty over the Group's ability to continue as a going concern.”
Group structure
- CREO MEDICAL GROUP PLC · parent
- Creo Medical Limited 100%
- Creo Medical, Inc. 100%
- Creo Medical Innovations Limited 100%
- Creo Medical PTE Ltd 100%
- Creo Medical S.L. 49%
- Medical S.L.U. & Creo Medical SLU 49%
Significant events
- “Sale of a 51% stake in Creo Medical Europe (CME) in FY25 generated £26.2m profit on disposal.”
- “First dividend from Creo Medical Europe of £1.6m (including £0.3m relating to tax losses) for FY25.”
- “Speedboat Notch launched in April 2025, is creating maximal contribution to growth.”
- “SpyderBlade Flex has achieved a strong early clinical recollection following regulatory approval and its commercial launch.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CRAVEN, Richard Gary | Secretary | 2024-07-01 | — | — |
| BOUCHER, Brent Jay | Director | 2024-07-01 | Jul 1967 | American |
| CANTU, Ivonne | Director | 2020-02-01 | Jul 1968 | Mexican |
| CROFTON, Kevin Timothy | Director | 2024-07-01 | Mar 1961 | American,British |
| GULLIFORD, Craig Jonathan | Director | 2016-09-12 | May 1970 | British |
| REES, Richard John | Director | 2016-09-12 | May 1976 | Welsh |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| REES, Richard | Secretary | 2016-09-12 | 2024-07-01 |
| BRADSHAW, John | Director | 2016-12-08 | 2025-05-22 |
| HANCOCK, Christopher Paul, Professor | Director | 2016-09-12 | 2025-06-26 |
| SPICER, Charles Alexander Evan, Dr | Director | 2016-12-05 | 2024-07-01 |
| WOODS, David Gerard | Director | 2016-11-30 | 2025-06-26 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 118 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-07-02 RESOLUTIONS Resolution
- 2024-10-27 RESOLUTIONS Resolution
- 2024-07-01 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-18 | AA | accounts | Accounts with accounts type group | |
| 2026-05-27 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2026-05-21 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-09-16 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-02 | RESOLUTIONS | resolution | Resolution | |
| 2025-06-27 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-26 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-11 | AA | accounts | Accounts with accounts type group | |
| 2025-05-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-22 | SH01 | capital | Capital allotment shares | |
| 2024-10-27 | RESOLUTIONS | resolution | Resolution | |
| 2024-10-22 | SH01 | capital | Capital allotment shares | |
| 2024-09-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-08-06 | SH01 | capital | Capital allotment shares | |
| 2024-07-02 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-07-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-02 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-07-01 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-01 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.